Autolus Therapeutics holder reports 3.5% stake
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Autolus Therapeutics plc (AUTL) is the issuer of the depositary receipts for which Qatar Investment Authority reported beneficial ownership of 9,184,404 shares, equal to 3.5% of the class, as of September 30, 2026. Qatar Investment Authority reports sole voting and dispositive power over all 9,184,404 shares, with no shared voting or dispositive power. Qatar Holding LLC, its wholly owned subsidiary, holds the securities.
Key Figures
Key Terms
beneficially owned regulatory
Sole Voting Power regulatory
Sole Dispositive Power regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many AUTL depositary receipts does Qatar Investment Authority beneficially own?
What percentage of AUTL does Qatar Investment Authority own?
AI-generated analysis. How Rhea-AI works. Not financial advice.